期刊文献+

子宫内膜癌中诱导型一氧化氮合酶表达及与肿瘤血管形成关系

Expression of Inducible Nitric Oxide Synthase in Endometrial Carcinoma and Its Relation to Carcinoangiogenesis
下载PDF
导出
摘要 [目的]探讨诱导型一氧化氮合酶(induciblenitricoxidesynthase,iNOS)在子宫内膜癌组织中表达及与肿瘤血管形成的关系。[方法]采用免疫组化S-P法检测30例子宫内膜癌组织中iNOS和血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)的表达和微血管密度(microvesseldensity,MVD)。[结果]iNOS在30例子宫内膜癌组织中的阳性表达率为73.3%;而对照组正常子宫内膜均未见表达。子宫肌层浸润深度>1/2的iNOS表达明显高于肌层未受累或≤1/2的患者(100%vs57.9%,P<0.05)。iNOS表达阳性组和阴性组MVD均值分别为45.6±3.5和20.8±4.5,两组比较差异有显著性(P<0.01)。iNOS的表达与VEGF及MVD均呈正相关(r=0.95,P<0.01;r=0.25,P<0.01)。[结论]iNOS在子宫内膜癌组织中的高表达与肿瘤血管形成及子宫肌层浸润程度的密切相关性,提示iNOS的高表达可能参与诱导肿瘤血管的形成。 To investigate the expression of inducible nitric oxide synthase (iNOS) in endometrial carcinoma and its relation to angiogenesis.The expression of iNOS,vascular endothelial growth factor(VEGF)and microvessel density (MVD) in 30 cases with endometrial carcinoma was evaluated by immunohistochemistry S-P staining.The positive expression rate of iNOS in 30 cases with endometrial carcinoma was 73.3%,but no expression in normal endometrium. The positive rate of iNOS was significantly higher in the cases with myometrium invasion with invasion depth over 1/2 than that in the cases with myometrium invasion less than 1/2(100% vs 57.9%,P<0.05).The value of MVD was 45.6±3.5 and 20.8±4.5 in positive and negative expression of iNOS respectively.There was significant difference between two groups(P<0.01).The expression of iNOS was positively correlated with expression of VEGF and MVD (r =0.95, P<0.01;r=0.25, P<0.01, respectively.[Conclusions]The high expression of iNOS in endometrium carcinoma is closely related to angiogenesis and myometrium invasion. It reveals that the high expression iNOS may participate in tumor angiogenesis.
出处 《中国肿瘤》 CAS 2005年第1期59-62,共4页 China Cancer
关键词 一氧化氮合酶 子宫内膜癌 血管形成 免疫组织化学 nitric oxide synthase endometrial carcinoma angiogenesis immunohistochemistry
  • 相关文献

参考文献22

  • 1Hamaoka R,Yaginuma Y,Takahashi T,et al.Different expression patterns of nitric oxide synthase isozymes in various gynecological cancers [J]. J Cancer Res Clin Oncol, 1999,125 (6):321-326.
  • 2Weidner N.Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J]. Breast Cancer Res Treat, 1995,36 (2):169-180.
  • 3Rajnakova A, Moochhala S, Goh PM, et al. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer [J]. Cancer Lett,2001, 172 (2):177-185.
  • 4Lee JC, Chow NH, Wang ST, et al. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients [J ].Eur J Cancer, 2000, 36 (6):748-753.
  • 5Ambs S, Merriam WG, Bennett WP, et al. Frequent nitric oxide synthease-2 expression in human colon adenomas:implication for tumor angiogenesis and colon cancer progression[J].Cancer Res,1998,58 (2):334-341.
  • 6Chin K, Kurashima Y, Ogura T, et al. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells[J].Oncogene, 1997, 15 (4): 437-442.
  • 7Moochhala S, Rajnakova A. Role of nitric oxide in cancer biology[J]. Free Radic Res, 1999,31(6): 671-679.
  • 8Kimura H, Weisz A, Kurashima Y, et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation bynitric oxide: control of hy poxia-inducible factor-1 activity by nitric oxide[J]. Blood, 2000, 95 (1):189-197.
  • 9Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer[J]. J Natl Cancer Inst, 1998, 90 (8):587-596.
  • 10Vriese AS, Tilton RG, Elger M, et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes [J]. J Am Soc Nephrol, 2001,12 (5):993-1000.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部